Gennex Laboratories Limited (BSE: GENNEX.BO) AI-Powered Stock Analysis
See how Gennex Laboratories Limited scores across key metrics like financial growth, valuation, and market position on the BSE, using AI-driven evaluation.
GENNEX.BO●BSE
HealthcareMedical - Pharmaceuticals
₹8.70
₹0.15(1.69%)
Indian Market opens in 51h 2m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerGennex Laboratories Limited (BSE: GENNEX.BO) Stock Overall Grade
Gennex Laboratories Limited's grade for its BSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Gennex Laboratories Limited's overall BSE stock rating.
Forecast
C+Score
58/100Financial Growth
CScore
40/100Fundamental Growth
CScore
41/100Key Ratios
B+Score
75/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/100Gennex Laboratories Limited (BSE: GENNEX.BO) AI-Powered Stock Analysis
On the BSE, GENNEX.BO demonstrates Good performance with an overall Forecast Score of 58/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (41/100, C) highlight its stability, while Key Ratios (75/100, B+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), the BSE-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(BSE: GENNEX.BO) Component Analysis Explained
Understand the key factors behind each Gennex Laboratories Limited (BSE: GENNEX.BO) stock grade, including financials, comparisons, and forecasts.